User login
Key clinical point: Applying a criterion of three lesions with the central vein sign distinguishes between multiple sclerosis and its mimics.
Major finding: The criterion has a sensitivity and specificity of 61.9% and 89.0%, respectively.
Study details: A multicenter study of 606 participants with clinically isolated syndrome, multiple sclerosis, and multiple sclerosis mimics.
Disclosures: Dr. Sinnecker reported receiving personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion.
Citation: Sinnecker T et al. AAN 2019, Abstract S6.002.
Key clinical point: Applying a criterion of three lesions with the central vein sign distinguishes between multiple sclerosis and its mimics.
Major finding: The criterion has a sensitivity and specificity of 61.9% and 89.0%, respectively.
Study details: A multicenter study of 606 participants with clinically isolated syndrome, multiple sclerosis, and multiple sclerosis mimics.
Disclosures: Dr. Sinnecker reported receiving personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion.
Citation: Sinnecker T et al. AAN 2019, Abstract S6.002.
Key clinical point: Applying a criterion of three lesions with the central vein sign distinguishes between multiple sclerosis and its mimics.
Major finding: The criterion has a sensitivity and specificity of 61.9% and 89.0%, respectively.
Study details: A multicenter study of 606 participants with clinically isolated syndrome, multiple sclerosis, and multiple sclerosis mimics.
Disclosures: Dr. Sinnecker reported receiving personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion.
Citation: Sinnecker T et al. AAN 2019, Abstract S6.002.